Clinical Trial Update: Experimental Vaccine for Prevention of Ebola Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of an experimental Ebola virus vaccine conducted by NIAID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Hemorrhagic Fever, Ebola Virus Disease | Phase 1 | Status: COMPLETED